Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.220
+0.070 (6.09%)
Apr 27, 2026, 11:03 AM EDT - Market open

Inovio Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
100120661393951,085
Market Cap Growth
71.47%81.73%-52.55%-64.74%-63.60%-27.65%
Enterprise Value
45.0868.09-18.684.96171.09713.85
Last Close Price
1.221.741.836.1218.7259.88
PE Ratio
--0.96-0.46-1.00-1.33-3.43
PS Ratio
1442.061837.29303.38167.3338.47611.21
PB Ratio
3.294.980.961.191.782.71
P/TBV Ratio
2.433.390.731.161.672.61
P/FCF Ratio
--1.35-0.63-1.12-1.82-5.00
P/OCF Ratio
--1.35-0.63-1.12-1.83-5.03
EV/Sales Ratio
689.961041.99-85.805.9616.67402.22
EV/EBITDA Ratio
--0.810.17-0.04-0.65-2.41
EV/EBIT Ratio
--0.780.17-0.03-0.64-2.37
EV/FCF Ratio
--0.770.18-0.04-0.79-3.29
Debt / Equity Ratio
0.270.270.140.090.130.08
Debt / EBITDA Ratio
-0.11-0.11-0.11-0.21-0.12-0.11
Debt / FCF Ratio
-0.10-0.10-0.11-0.24-0.15-0.15
Net Debt / Equity Ratio
-2.04-2.04-1.20-0.98-0.99-0.92
Net Debt / EBITDA Ratio
0.590.590.750.820.841.24
Net Debt / FCF Ratio
0.550.550.790.921.021.70
Asset Turnover
0.000.000.000.000.020.00
Quick Ratio
1.341.342.663.472.736.23
Current Ratio
1.401.402.773.603.256.82
Return on Equity (ROE)
-183.47%-183.47%-115.42%-79.55%-89.97%-70.55%
Return on Assets (ROA)
-92.61%-92.61%-79.11%-55.42%-63.37%-58.17%
Return on Invested Capital (ROIC)
-4919.88%-4919.88%-11927.90%-4493.10%-1333.16%-454.87%
Return on Capital Employed (ROCE)
-160.02%-160.02%-108.99%-75.75%-78.48%-64.90%
Earnings Yield
-90.15%-104.02%-215.85%-99.51%-75.16%-29.14%
FCF Yield
-94.36%-74.06%-158.28%-89.56%-55.01%-20.00%
Buyback Yield / Dilution
-72.63%-72.62%-22.49%-11.51%-14.27%-34.62%
Total Shareholder Return
-72.63%-72.62%-22.49%-11.51%-14.27%-34.62%
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q